13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 46 holding rows worth $339,791,000.
- Accession
- 0001387131-18-003948
- Filer
- CIK 1595851
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 46 entries on the cover page, a total value of $339,791,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $339,791,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOMEDICS INC | 452907108 | COM | 1,250,000 | $29,588,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 500,000 | $24,650,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 175,000 | $23,132,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 675,000 | $22,768,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 210,000 | $20,683,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 105,000 | $16,480,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 150,000 | $12,429,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 175,000 | $11,641,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 242,000 | $10,938,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 600,000 | $10,716,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 700,000 | $9,520,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 235,000 | $9,214,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 400,000 | $8,608,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 535,000 | $8,169,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 660,000 | $8,085,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 295,000 | $7,620,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 1,900,000 | $7,581,000 | thousands by filing date | |
| ENDOCYTE INC | 29269A102 | COM | 500,000 | $6,900,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 350,000 | $6,871,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 23,500 | $6,573,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 230,000 | $6,569,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 400,000 | $6,452,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 900,000 | $6,228,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 400,000 | $6,056,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 186,019 | $5,562,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 125,000 | $4,776,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 360,000 | $4,608,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 230,000 | $4,186,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 1,411,247 | $4,163,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 355,000 | $4,143,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 185,000 | $4,070,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 600,000 | $3,750,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 250,000 | $3,400,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 3,525,000 | $3,016,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 450,000 | $2,759,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 15,700 | $1,115,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 102,263 | $1,046,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 33,000 | $947,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 14,000 | $828,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 750,792 | $773,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P108 | COM | 100,000 | $719,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 52,000 | $684,000 | thousands by filing date | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 29,000 | $608,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 5,000 | $525,000 | thousands by filing date | put |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 2,000 | $520,000 | thousands by filing date | call |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 2,000 | $122,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-18-003948 | this filing | 2018-08-14 | acceptance time not in the bulk data set |